Patent details
LUC00301 Product Name: teclistamab
Basic Information
- Publication number:
- LUC00301
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP167541481
- Legal Status:
- Inactive
- Application number:
- LUC00301
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/22/1675
- Marketing Authorization Type:
- Marketing Authorization Date:
- 24/08/2022
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 22/02/2023
- First Marketing Authorization date:
- 24/08/2022
- Grant date:
- 22/09/2025
- Activation date:
- Publication date:
- 23/02/2023
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 24/08/2037
- SPC Extension Expiration:
- 24/08/2037
- Rejection date:
- Withdrawal date:
Owner
- From:
- 13/03/2023
- Name:
- JANSSEN BIOTECH, INC.
- Address:
- 800/850 RIDGEVIEW DRIVE, HORSHAM, PA 19044, United States (US)
History of Owners
- From:
- 22/02/2023
- To:
- 13/03/2023
- Name:
- Janssen Pharmaceutica NV
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
Agent
- Name:
- Dennemeyer & Associates S.A.
- From:
- 22/02/2023
- Address:
- 55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2023/05
- Publication date:
- 04/04/2023
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
2
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2023/03
- Publication date:
- 01/03/2023
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
3
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2025/11
- Publication date:
- 02/10/2025
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20230000114A
- Date Registered:
- 13/03/2023
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- Dennemeyer & Associates S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- JANSSEN BIOTECH, INC.
- Address:
- 800/850 RIDGEVIEW DRIVE, HORSHAM, PA 19044, United States (US)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 01/09/2036
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 22/02/2023 | Application Form | 8 |
| 22/02/2023 | Summary of the product caracteristics | 51 |
| 22/02/2023 | Summary of the product caracteristics | 51 |
| 22/02/2023 | MA publication | 8 |
| 22/02/2023 | Marketing authorization | 3 |
| 23/02/2023 | Outgoing Correspondence | 1 |
| 13/03/2023 | Request For Change | 1 |
| 16/03/2023 | Outgoing Correspondence | 1 |
| 23/02/2023 | Publication | 1 |
| 22/09/2025 | Publication | 1 |
| 22/09/2025 | Certificate | 1 |
| 22/09/2025 | Outgoing Correspondence | 1 |